Annual ROE
-16.86%
-1706.60%-101.00%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual return on equity is -16.86%, with the most recent change of -1706.60% (-101.00%) on December 31, 2023.
- During the last 3 years, TBPH annual ROE has fallen by -108.39% (-118.42%).
- TBPH annual ROE is now -101.00% below its all-time high of 1689.74%, reached on December 31, 2022.
Performance
TBPH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-23.67%
-3.61%-18.00%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly return on equity is -23.67%, with the most recent change of -3.61% (-18.00%) on September 30, 2024.
- Over the past year, TBPH quarterly ROE has dropped by -7.99% (-50.96%).
- TBPH quarterly ROE is now -101.50% below its all-time high of 1577.67%, reached on December 31, 2022.
Performance
TBPH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TBPH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -101.0% | -51.0% |
| 3 y3 years | -118.4% | -134.1% |
| 5 y5 years | +97.5% | -119.7% |
TBPH ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -101.0% | at low | -101.5% | +96.1% |
| 5 y | 5-year | -101.0% | at low | -101.5% | +96.1% |
| alltime | all time | -101.0% | +97.5% | -101.5% | +96.8% |
Theravance Biopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -23.67%(+18.0%) |
| Jun 2024 | - | -20.06%(+17.8%) |
| Mar 2024 | - | -17.03%(-4.3%) |
| Dec 2023 | -16.86%(-101.0%) | -17.79%(+13.5%) |
| Sep 2023 | - | -15.68%(-104.4%) |
| Jun 2023 | - | 355.00%(-52.0%) |
| Mar 2023 | - | 740.26%(-53.1%) |
| Dec 2022 | 1689.74%(+2768.8%) | 1577.67%(-359.4%) |
| Sep 2022 | - | -608.28%(-2143.3%) |
| Jun 2022 | - | 29.77%(-32.9%) |
| Mar 2022 | - | 44.35%(-25.7%) |
| Dec 2021 | 58.90%(-35.6%) | 59.72%(-14.0%) |
| Sep 2021 | - | 69.43%(-18.6%) |
| Jun 2021 | - | 85.29%(-11.4%) |
| Mar 2021 | - | 96.29%(-19.9%) |
| Dec 2020 | 91.53%(-13.4%) | 120.15%(-10.9%) |
| Sep 2020 | - | 134.90%(-4.2%) |
| Jun 2020 | - | 140.81%(+0.0%) |
| Mar 2020 | - | 140.74%(-2.2%) |
| Dec 2019 | 105.64% | 143.93%(-21.1%) |
| Sep 2019 | - | 182.35%(-35.2%) |
| Jun 2019 | - | 281.50%(-54.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | 619.93%(-185.1%) |
| Dec 2018 | -677.87%(+452.7%) | -728.43%(+121.6%) |
| Sep 2018 | - | -328.77%(+61.6%) |
| Jun 2018 | - | -203.46%(+28.1%) |
| Mar 2018 | - | -158.82%(+31.8%) |
| Dec 2017 | -122.65%(+90.8%) | -120.46%(+23.9%) |
| Sep 2017 | - | -97.21%(+25.6%) |
| Jun 2017 | - | -77.39%(+8.7%) |
| Mar 2017 | - | -71.18%(+8.4%) |
| Dec 2016 | -64.27%(-6.0%) | -65.69%(+3.4%) |
| Sep 2016 | - | -63.52%(-10.2%) |
| Jun 2016 | - | -70.72%(-2.7%) |
| Mar 2016 | - | -72.70%(+3.9%) |
| Dec 2015 | -68.39%(-60.7%) | -69.97%(-2.9%) |
| Sep 2015 | - | -72.09%(+7.8%) |
| Jun 2015 | - | -66.90%(-21.6%) |
| Mar 2015 | - | -85.37%(-29.5%) |
| Dec 2014 | -173.81%(-118.9%) | -121.01%(-3.8%) |
| Sep 2014 | - | -125.75%(-27.9%) |
| Jun 2014 | - | -174.43%(-116.6%) |
| Mar 2014 | - | 1053.64%(+14.8%) |
| Dec 2013 | 917.43% | 917.43% |
FAQ
- What is Theravance Biopharma annual return on equity?
- What is the all time high annual ROE for Theravance Biopharma?
- What is Theravance Biopharma annual ROE year-on-year change?
- What is Theravance Biopharma quarterly return on equity?
- What is the all time high quarterly ROE for Theravance Biopharma?
- What is Theravance Biopharma quarterly ROE year-on-year change?
What is Theravance Biopharma annual return on equity?
The current annual ROE of TBPH is -16.86%
What is the all time high annual ROE for Theravance Biopharma?
Theravance Biopharma all-time high annual return on equity is 1689.74%
What is Theravance Biopharma annual ROE year-on-year change?
Over the past year, TBPH annual return on equity has changed by -1706.60% (-101.00%)
What is Theravance Biopharma quarterly return on equity?
The current quarterly ROE of TBPH is -23.67%
What is the all time high quarterly ROE for Theravance Biopharma?
Theravance Biopharma all-time high quarterly return on equity is 1577.67%
What is Theravance Biopharma quarterly ROE year-on-year change?
Over the past year, TBPH quarterly return on equity has changed by -7.99% (-50.96%)